Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis

被引:197
|
作者
Varela, E. [1 ]
Manichanh, C. [1 ]
Gallart, M. [1 ]
Torrejon, A. [1 ]
Borruel, N. [1 ]
Casellas, F. [1 ]
Guarner, F. [1 ]
Antolin, M. [1 ]
机构
[1] Univ Autonoma Barcelona, Univ Hosp Vall dHebron, Inst Recerca Vall dHebron, Dept Gastroenterol,Digest Syst Res Unit, E-08193 Barcelona, Spain
关键词
INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; MICROBIAL DIVERSITY; DIETARY FIBER; MUCOSA; TWIN; IMBALANCES; MODEL; FLORA;
D O I
10.1111/apt.12365
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Although incrimination of the intestinal microbiota in the pathogenesis of IBD is widely accepted, few data are available about the role of specific bacteria. Potentially, Faecalibacterium prausnitzii, bacteria with anti-inflammatory properties, might be deficient in ulcerative colitis (UC). Aim To quantify F.prausnitzii in the faecal microbiota of UC patients in remission and determine its relationship with relapse. Methods A cross-sectional study included 116 UC patients in remission, 29 first-degree relatives and 31 healthy controls. A subset of eighteen patients, recruited during the first month of remission, underwent a 1-year follow-up. Total bacteria and F.prausnitzii were measured by quantitative Real Time PCR (qPCR, copies/g). Calprotectin was determined as inflammatory index (g/g). Results We found that F.prausnitzii was reduced in patients (median, IQR: 1.4x108, 5.1x107-4.5x108) and relatives (1.7x108, 9.3x107-5.1x108) vs. controls (6.5x108, 3.7x108-1.6x109, P<0.0001). Moreover, low counts of F.prausnitzii were associated with less than 12months of remission (8.0x107, 2.0x107-3.5x108 vs. 2.1x108, 1.0x108-7.9x108, P<0.001) and more than 1 relapse/year (8.0x107, 3.2x107-3.8x108 vs. 1.9x108, 6.8x107-6.0x108, P<0.01). When patients were followed up, F.prausnitzii increased steadily until reaching similar levels to those of controls if remission persisted (2.9x108, 9.3x106-1.2x109; calprotectin: 76, 19-212), whereas it remained low if patients relapsed (2.2x108, 1.4x106-3.3x108; calprotectin: 1760, 844-3662 P<0.05 vs. controls). Conclusions Defective gut colonisation by F.prausnitzii occurred in UC patients during remission and in their unaffected relatives. The recovery of the F.prausnitzii population after relapse is associated with maintenance of clinical remission.
引用
收藏
页码:151 / 161
页数:11
相关论文
共 50 条
  • [1] Colonization by Faecalibacterium Prausnitzii and Maintenance of Clinical Remission in Patients With Ulcerative Colitis
    Varela, Encama
    Antolin, Maria
    Manichanh, Chaysavanh
    Gallart, Milagros
    Casellas, Moniserrat
    Torrejon, Antonio
    Borruel, Natalia
    Casellas, Francesc
    Guarner, Francisco
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S47 - S47
  • [2] Commentary: is Faecalibacterium prausnitzii a potential treatment for maintaining remission in ulcerative colitis?
    Siaw, Y. H.
    Hart, A.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (05) : 551 - 551
  • [3] Association of Faecalibacterium Prausnitzii and Disease Activity in Ulcerative Colitis
    Machiels, Kathleen
    Joossens, Marie
    De Preter, Vicky
    Arijs, Ingrid
    Ballet, Vera
    Organe, Sophie
    Coopmans, Tamara
    Van Assche, Gert A.
    Verhaegen, Jan
    Rutgeerts, Paul J.
    Vermeire, Severine
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S142 - S142
  • [4] OLSALAZINE IN MAINTENANCE OF CLINICAL REMISSION IN PATIENTS WITH ULCERATIVE-COLITIS
    WRIGHT, JP
    OKEEFE, EA
    CUMING, L
    JASKIEWICZ, K
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (10) : 1837 - 1842
  • [5] MAINTENANCE WITH FAECAL MICROBIOTA TRANSPLANTATION ENHANCES DEEP REMISSION IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL REMISSION
    Midha, Vandana
    Singh, Arshdeep
    Mahajan, Ramit
    Mehta, Varun
    Khattar, Husanpreet
    Narang, Vikram
    Sood, Ajit
    [J]. GUT, 2018, 67 : A74 - A74
  • [6] The Role of Akkermansia muciniphila and Faecalibacterium prausnitzii in the Pathogenesis of Ulcerative Colitis and Crohn's Disease
    Kurt, Enes A.
    Demirci, Mehmet
    Ozbey, Dogukan
    Gareayaghi, Nesrin
    Eskazan, Tugce
    Erzin, Yusuf Z.
    Cakan, Huseyin
    Saribas, Suat
    Bal, Kadir
    Kocazeybek, Bekir
    [J]. CLINICAL LABORATORY, 2024, 70 (01) : 157 - 166
  • [7] Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis
    Colombel, Jean-Frederic
    Osterman, Mark T.
    Thorpe, Andrew J.
    Salese, Leonardo
    Nduaka, Chudy I.
    Zhang, Haiying
    Lawendy, Nervin
    Friedman, Gary S.
    Quirk, Daniel
    Su, Chinyu
    Reinisch, Walter
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (01) : 116 - +
  • [8] A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis
    Machiels, Kathleen
    Joossens, Marie
    Sabino, Joao
    De Preter, Vicky
    Arijs, Ingrid
    Eeckhaut, Venessa
    Ballet, Vera
    Claes, Karolien
    Van Immerseel, Filip
    Verbeke, Kristin
    Ferrante, Marc
    Verhaegen, Jan
    Rutgeerts, Paul
    Vermeire, Severine
    [J]. GUT, 2014, 63 (08) : 1275 - 1283
  • [9] Low Counts of Faecalibacterium prausnitzii in Colitis Microbiota
    Sokol, H.
    Seksik, P.
    Furet, J. P.
    Firmesse, O.
    Nion-Larmurier, L.
    Beaugerie, L.
    Cosnes, J.
    Corthier, G.
    Marteau, P.
    Dore, J.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (08) : 1183 - 1189
  • [10] Curcumin for maintenance of remission in ulcerative colitis
    Kumar, Sushil
    Ahuja, Vineet
    Sankar, Mari Jeeva
    Kumar, Atul
    Moss, Alan C.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (10):